University Hospital, Toulouse: Prader-Willi Syndrome trials
The registry lists 17 Prader-Willi Syndrome studies with University Hospital, Toulouse as lead sponsor. 6 are open to participants now and 1 have results posted.
Phase 1 2Phase 2 5Phase 3 4Phase 4 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Brain Olfactory Pathways in Prader-Willi SyndromeNot yet recruitingNCT07006207Not applicable
- Autistic Symptomatology and Sensory Profile in Children With Prader-Willi SyndromeRecruitingNCT06877715
- Adolescent Projections During Transition in Prader-Willi SyndromeNot yet recruitingNCT06279052Not applicable
- Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical TrialRecruitingNCT05032326Phase 3
- Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or ObesityRecruitingNCT04768803
- Register of Patients With Prader-Willi SyndromeRecruitingNCT02829684
- Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS InfantsCompletedNCT02205034Phase 1/2Results posted
- Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi SyndromeCompletedNCT05298085Phase 2/3
- Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative RemediationCompletedNCT04526379Not applicable
- Oxytocin Treatment in Neonates and Infants With Prader-Willi SyndromeCompletedNCT04283578Phase 3
- Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 YearsCompletedNCT03114371Not applicable
- Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.CompletedNCT03081832Not applicable
- Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi SyndromeCompletedNCT02804373Phase 2/3
- PWS European Blood Bank for Infants and Controls From 0 to 48 MonthsCompletedNCT02529085Not applicable
- Tolerance of Intranasal Administration of OT in Prader-Willi Newborn BabiesCompletedNCT01548521Phase 1/2
- Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?CompletedNCT01298180Phase 4
- Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus PlaceboCompletedNCT01038570Phase 2